BOLD vs MTD · P/E 0.1, $24.6M cap vs P/E 27, rev $3.87B
Boundless Bio, Inc. Common Stock (BOLD) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
BOLD does not have a complete income-statement cache yet.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the BOLD and MTD stock pages for the full models.
Not investment advice.